CONSORTIUM

The ProCAncer-I project brings together 20 partners, including PCa centers of reference, world leaders in AI and innovative SMEs, with recognized expertise in their respective domains, with the objective to design, develop and sustain a cloud-based, secure European Image Infrastructure with tools and services for data handling.

Foundation for Research and Technology Hellas (FORTH) COORDINATOR

Greece | Manolis Tsiknakis (Project Coordinator) 

FORTH is the Project Coordinator of ProCAncer-I

RadboudUMC (RUN)

The Netherlands | Jurgen Fütterer

University of Pisa (UNIPI)

Italy | Emanuele Neri

Hacettepe University, School of Medicine, Department of Radiology (HACETTEPE)

Turkey | Deniz Akata

 JCC Diagnostic Imaging (VDC)

Portugal | João Carlos Costa

General Anti-Cancer and Oncological Hospital of Athens, “St. Savvas” (GAONA)

Greece | Vasileios Katsaros

Royal Marsden National Health Service Trust (ICR)

United Kingdom| Dow-Mu Koh

QS Instituto de Investigacion e Innovacion SL (QUIRON)

Spain | Rocio Diaz-Sanchez

Consiglio Nazionale delle Ricerche (CNR)

Italy | Sara Colantonio

ADVANTIS Medical Imaging Single Member PC (ADVANTIS)

Greece | Zoi Giavri

Fundacao D. Anna Sommer Champalimaud e Dr. Carloss Montez Champalimaud (CF)

Portugal | Nikolaos Papanikolaou

Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana (HULAFE)

Spain | Luis Marti Bonmati

Institut Paoli Calmettes (PCAL)

France | Jochen Walz

Fundacio Institut D’Investigacio Biomedica De Girona Doctor Josep Trueta (IDIBGI)

Spain | Joan C. Vilanova

National Cancer Institute (NCIV)

Lithuania | Jurgita Ušinskienė

Candiolo Cancer Institute, FPO – IRCCS (FPO)

Italy | Daniele Regge

Massachusetts General Hospital (The General Hospital Corp) (QTIM)

USA | Jayashree Kalpathy-Cramer

Biotronics 3D Limited (B3D)

UK | Joao Correia

University of Vienna (UNIVIE)

Austria | Nikolaus Forgó

QUIBIM, Sociedad Limitada (QUIBIM)

Spain | Angel ALBERICH-BAYARRI

Highlights

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I at the ECR 2025 in Vienna

ProCAncer-I will organise a Dedicated Session on the project during the European Congress of Radiology 2025 on the 26th of February 2025, at 15.00-16.00, with the title "ProCAncer-I: an AI platform integrating multiparametric MRI and AI models" where we will present...

Twitter feed is not available at the moment.

Stay in touch!